系统的突变分析揭示了N275在IgE稳定性中的重要作用
Shikha Kumari1,2,3, Sanjay Ghosh2, Saurabh Joshi3
1Manipal Academy of Higher Education, Manipal, India.
Biotechnology and bioengineering
|August 21, 2024
概括
这项研究表明,N-链接的N275糖化对IgE分泌和稳定性至关重要,但脱糖化提高了治疗疗效,挑战了关于抗体糖化在癌症治疗中的现有观念.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 结构生物学 结构生物学
背景情况:
- 治疗性抗体传统上依赖于IgG,但IgE抗体正在癌症治疗中出现.
- IgE糖化研究是有限的,关于其在FcεRI结合和功能中的作用的数据是相互矛盾的.
- 了解IgE糖化是开发基于抗体的新型癌症治疗的关键.
研究的目的:
- 系统地研究IgE重链中的N链糖化位点的功能意义.
- 澄清N275残留物在IgE分泌,稳定性和受体结合中的作用.
- 探索脱糖化IgE变体作为增强癌症治疗的潜力.
主要方法:
- 位点定向的突变发生改变了IgE重链上的N链糖化位点.
- 在体外测试以评估IgE分泌,稳定性和FcεRI结合.
- 功能性测试用于评估脱糖化IgE变体的疗效.
主要成果:
- N275残留物对IgE分泌和稳定性至关重要.
- 在N275的突变没有影响体外IgE功能,但用酸替代降低了抗体产量.
- 脱糖化IgE变体与糖化IgE变体相比,显示出更高的治疗效果.
结论:
- IgE糖化与抗体结构和功能有着复杂的关系.
- N275残留物在IgE分泌和稳定性中起着关键作用.
- 降糖化IgE可能为开发更有效,更稳定的IgE基础的癌症疗法提供了一种战略.
相关概念视频
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K


